ArticleTherapeutic advances in medical oncology2026
Timing of immune checkpoint inhibitor infusion predicts survival in advanced esophageal squamous cell carcinoma: A retrospective cohort study.
Wenjing Wang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.